Reports for ACCORD HEALTHCARE INC
Company Name
ACCORD HEALTHCARE INC
Totals |
||
Shortage reports |
313 |
|
Actual shortage: | 57 (18%) | |
Anticipated shortage: | 13 (4%) | |
Avoided shortage: | 2 (1%) | |
Resolved: | 241 (77%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
21 (7%) |
|
Overdue reports |
1 (1%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACH-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-07-18 | 2022-08-08 | 164800 |
ACH-LACOSAMIDE | 50MG | TABLET | Actual shortage | 2022-09-22 | 2022-10-05 | 169848 |
ACH-LACOSAMIDE | 100MG | TABLET | Actual shortage | 2022-09-22 | 2022-10-05 | 169857 |
ACH-LACOSAMIDE | 150MG | TABLET | Actual shortage | 2022-09-22 | 2022-10-05 | 169864 |
ACH-LACOSAMIDE | 200MG | TABLET | Actual shortage | 2022-09-22 | 2022-10-05 | 169869 |
METHOTREXATE SUBCUTANEOUS | 17.5MG | SOLUTION | Resolved | 2022-11-25 | 2023-06-30 | 175814 |
ACH-ATORVASTATIN CALCIUM | 80MG | TABLET | Resolved | 2022-11-25 | 2022-12-10 | 175819 |
ACH-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-11-25 | 2023-02-25 | 175826 |
ACH-ESCITALOPRAM | 10MG | TABLET | Resolved | 2022-11-25 | 2023-02-25 | 175829 |
ACH-OLMESARTAN | 40MG | TABLET | Resolved | 2022-11-25 | 2023-01-10 | 175832 |
ACH-METHOTREXATE | 2.5MG | TABLET | Resolved | 2022-11-25 | 2023-02-25 | 175835 |
ACH-APIXABAN | 5MG | TABLET | Resolved | 2022-11-25 | 2023-02-04 | 175838 |
ACH-ATORVASTATIN CALCIUM | 40MG | TABLET | Resolved | 2022-12-02 | 2022-12-19 | 177024 |
ACH-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-12-02 | 2022-12-19 | 177027 |
ACH-OLMESARTAN | 40MG | TABLET | Resolved | 2022-12-02 | 2022-12-22 | 177030 |
ACH-APIXABAN | 5MG | TABLET | Resolved | 2022-12-02 | 2023-01-24 | 177033 |
ACH-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-12-02 | 2023-10-06 | 177036 |
ACH-ROSUVASTATIN | 10MG | TABLET | Resolved | 2022-12-02 | 2023-01-07 | 177039 |
ACH-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-12-02 | 2023-08-05 | 177042 |
METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-01-13 | 2023-01-28 | 181024 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0